These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 3340251

  • 21. Prednisolone and azathioprine in IgA nephropathy - a ten-year follow-up study.
    Goumenos DS, Davlouros P, El Nahas AM, Ahuja M, Shortland JR, Vlachojannis JG, Brown CB.
    Nephron Clin Pract; 2003; 93(2):C58-68. PubMed ID: 12616032
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Dual renin-angiotensin system blockade plus oral methylprednisone for the treatment of proteinuria in IgA nephropathy.
    Trimarchi H, Muryan A, Young P, Forrester M, Iotti A, Pereyra H, Lombi F, Seminario O, Alonso M, Iotti R.
    Medicina (B Aires); 2007; 67(5):445-50. PubMed ID: 18051227
    [Abstract] [Full Text] [Related]

  • 24. Prospective randomized controlled multicenter trial on steroids plus ramipril in proteinuric IgA nephropathy.
    Manno C, Gesualdo L, D'Altri C, Rossini M, Grandaliano G, Schena FP.
    J Nephrol; 2001; 14(4):248-52. PubMed ID: 11506246
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Cyclophosphamide pulse therapy in advanced progressive IgA nephropathy.
    Rasche FM, Klotz CH, Czock D, Karges W, Muche R, Jehle PM, Mertz A, Keller F.
    Nephron Clin Pract; 2003; 93(4):c131-6. PubMed ID: 12759581
    [Abstract] [Full Text] [Related]

  • 27. Controlled, prospective trial of steroid treatment in IgA nephropathy: a limitation of low-dose prednisolone therapy.
    Katafuchi R, Ikeda K, Mizumasa T, Tanaka H, Ando T, Yanase T, Masutani K, Kubo M, Fujimi S.
    Am J Kidney Dis; 2003 May; 41(5):972-83. PubMed ID: 12722031
    [Abstract] [Full Text] [Related]

  • 28. An "evidence-based" survey of therapeutic options for IgA nephropathy: assessment and criticism.
    Strippoli GF, Manno C, Schena FP.
    Am J Kidney Dis; 2003 Jun; 41(6):1129-39. PubMed ID: 12776264
    [Abstract] [Full Text] [Related]

  • 29. Advanced IgA nephropathy: to treat or not to treat?
    Locatelli F, Pozzi M, Del Vecchio L, Pozzi C.
    Nephron Clin Pract; 2003 Jun; 93(4):c119-21. PubMed ID: 12759578
    [No Abstract] [Full Text] [Related]

  • 30. Corticosteroid therapy in IgA nephropathy with nephrotic syndrome: a long-term controlled trial.
    Lai KN, Lai FM, Ho CP, Chan KW.
    Clin Nephrol; 1986 Oct; 26(4):174-80. PubMed ID: 3536231
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Prognostic factors and therapy assessment of IgA nephropathy: report from a single unit in iran.
    Soleymanian T, Najafi I, Salimi BH, Broomand B.
    Ren Fail; 2011 Oct; 33(6):572-7. PubMed ID: 21663387
    [Abstract] [Full Text] [Related]

  • 34. Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial.
    Lv J, Zhang H, Chen Y, Li G, Jiang L, Singh AK, Wang H.
    Am J Kidney Dis; 2009 Jan; 53(1):26-32. PubMed ID: 18930568
    [Abstract] [Full Text] [Related]

  • 35. Effect of fluvastatin and dipyridamole on proteinuria and renal function in childhood IgA nephropathy with mild histological findings and moderate proteinuria.
    Kano K, Nishikura K, Yamada Y, Arisaka O.
    Clin Nephrol; 2003 Aug; 60(2):85-9. PubMed ID: 12940609
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The predictive value of attenuated proteinuria at 1 year after steroid therapy for renal survival in patients with IgA nephropathy.
    Hirano K, Kawamura T, Tsuboi N, Okonogi H, Miyazaki Y, Ikeda M, Matsushima M, Hanaoka K, Ogura M, Utsunomiya Y, Hosoya T.
    Clin Exp Nephrol; 2013 Aug; 17(4):555-62. PubMed ID: 23224025
    [Abstract] [Full Text] [Related]

  • 38. Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population.
    Le W, Liang S, Hu Y, Deng K, Bao H, Zeng C, Liu Z.
    Nephrol Dial Transplant; 2012 Apr; 27(4):1479-85. PubMed ID: 21965586
    [Abstract] [Full Text] [Related]

  • 39. Clinical and histopathologic profile of patients with primary IgA nephropathy seen in a tertiary hospital in India.
    Bagchi S, Singh G, Yadav R, Kalaivani M, Mahajan S, Bhowmik D, Dinda A, Agarwal SK.
    Ren Fail; 2016 Apr; 38(3):431-6. PubMed ID: 26837482
    [Abstract] [Full Text] [Related]

  • 40. Oral calcitriol for the treatment of persistent proteinuria in immunoglobulin A nephropathy: an uncontrolled trial.
    Szeto CC, Chow KM, Kwan BC, Chung KY, Leung CB, Li PK.
    Am J Kidney Dis; 2008 May; 51(5):724-31. PubMed ID: 18436082
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.